Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Zymeworks Completes Acquisition of Theravance Biopharma

Zymeworks Completes Acquisition of Theravance Biopharma

MT newswireMT newswire2026/09/23 20:35
04:35 PM EDT, 09/23/2026 (MT Newswires) -- Zymeworks (ZYME) said late Wednesday it completed its previously announced $929 million acquisition of Theravance Biopharma. The deal advances Zymeworks' strategy to build a diversified biotechnology company combining research and development with commercial and royalty-based cash flows, it said.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!